Inventor · disambiguated record
Rana Rais
Also filed as: RAIS RANA
18 granted patents·13 pending applications·41 citations·filing 2015–2024
91Inventor score
Top patents by PatentIndex Score
31 records- 0194US10738066B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2019·Granted Aug 11, 2020·5 cites·18 claims
- 0294US10336778B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2018·Granted Jul 2, 2019·8 cites·4 claims
- 0393US10954257B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2019·Granted Mar 23, 2021·4 cites·19 claims
- 0491US9988407B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2015·Granted Jun 5, 2018·11 cites·11 claims
- 0589US11325931B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2020·Granted May 10, 2022·2 cites·19 claims
- 0683US11059775B2Prodrug compositions and utility of hydroxamate-based GCPII inhibitorsUNIV JOHNS HOPKINS·Filed 2017·Granted Jul 13, 2021·2 cites·1 claims
- 0782US11331271B2Buccal, sublingual and intranasal delivery of fospropofolUNIV JOHNS HOPKINS·Filed 2017·Granted May 17, 2022·2 cites·20 claims
- 0882US10849915B2Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitorsUNIV JOHNS HOPKINS·Filed 2018·Granted Dec 1, 2020·3 cites·3 claims
- 0980US10544176B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2018·Granted Jan 28, 2020·2 cites·4 claims
- 1078US12492160B2Prodrugs of itaconate and methyl itaconateUNIV JOHNS HOPKINS·Filed 2024·Granted Dec 9, 2025·0 cites·11 claims
- 1178US11932664B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2022·Granted Mar 19, 2024·0 cites·9 claims
- 1277US10172873B2Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitorsUNIV JOHNS HOPKINS·Filed 2015·Granted Jan 8, 2019·2 cites·16 claims
- 1376US12496284B2Use of itaconate and its derivatives/analogues to induce hair growthUNIV JOHNS HOPKINS·Filed 2024·Granted Dec 16, 2025·0 cites·16 claims
- 1475US11926640B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2021·Granted Mar 12, 2024·0 cites·16 claims
- 1573US11866394B2Prodrugs of hydroxamate-based GCPII inhibitorsUNIV JOHNS HOPKINS·Filed 2021·Granted Jan 9, 2024·0 cites·3 claims
- 1670US2023372499A1Dendrimer compositions and methods for drug deliveryUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1768US2023075584A1Intranasal administration of glutamate carboxypeptidase (gcp-ii) inhibitorsUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1863US2024415800A1Dopa and caffeic acid analogs as novel gcpii inhibitorsUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1963US2023028516A1Prodrugs of itaconate and methyl itaconateUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 2060US2021170040A1Dendrimer compositions and methods for drug deliveryASHVATTHA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2159US2024287108A1nSMASE2 INHIBITOR PRODRUGS WITH ENHANCED ORAL AND BRAIN EXPOSURESRAIS RANA·Filed 2022·Application pending·0 cites
- 2256US2024398962A1Dendrimer-glutamine antagonist conjugates and methods of use thereofUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 2356US2024024347A1Prodrugs of 6-mercaptopurineUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2454US2024246902A1Prodrugs of 6-diazo-5-oxo-l-norleucineUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 2552US2018338910A1Intranasal administration of glutamate carboxypeptidase (gcp-ii) inhibitorsUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
- 2652US2023416294A1Decitabine analogs for immunological and oncological therapyUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2751US2023218581A1Compositions and methods comprising dendrimers and therapeutic agentsUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2851US2023128984A1Bile acid-gcpii inhibitor conjugates to treat inflammatory diseases, including inflammatory bowel disease (ibd)UNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2950US11712435B2Mebendazole prodrugs with enhanced solubility and oral bioavailabilityUNIV JOHNS HOPKINS·Filed 2019·Granted Aug 1, 2023·0 cites·19 claims
- 3046US12195419B2Glutamine antagonists and uses thereofUNIV JOHNS HOPKINS·Filed 2018·Granted Jan 14, 2025·0 cites·24 claims
- 3143US12508271B2Prodrugs of 2-PMPA for healthy tissue protection during PSMA-targeted cancer imaging or radiotherapyUNIV JOHNS HOPKINS·Filed 2018·Granted Dec 30, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Rana Rais files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →